Nalaganje...

Sarcoma Immunotherapy: Past Approaches and Future Directions

Sarcomas are heterogeneous malignant tumors of mesenchymal origin characterized by more than 100 distinct subtypes. Unfortunately, 25–50% of patients treated with initial curative intent will develop metastatic disease. In the metastatic setting, chemotherapy rarely leads to complete and durable res...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: D'Angelo, S. P., Tap, W. D., Schwartz, G. K., Carvajal, R. D.
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981453/
https://ncbi.nlm.nih.gov/pubmed/24778572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/391967
Oznake: Označite
Brez oznak, prvi označite!